Package 0615-8602-39

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0615-8602-39
Digits Only 0615860239
Product NDC 0615-8602
Product ID 0615-8602_82d92152-92be-419f-a7a5-7b36b318ea1c
Description

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8602-39)

Marketing

Marketing Status
Marketed Since 2025-11-04
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "82d92152-92be-419f-a7a5-7b36b318ea1c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518"], "spl_set_id": ["1bd2ed35-35c5-464f-bf51-9dd4b42ee59a"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8602-39)", "package_ndc": "0615-8602-39", "marketing_start_date": "20251104"}], "brand_name": "Bupropion hydrochloride", "product_id": "0615-8602_82d92152-92be-419f-a7a5-7b36b318ea1c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0615-8602", "generic_name": "Bupropion hydrochloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}